BIOTECHNOLOGY VALUE FUND L P

CIK: 0000918923·Pooled Investment Fund·SAN FRANCISCO, CA

Reported Sold

$1,512,332,682

Total Filings

16

Identified Offerings

1

Last Filed

Dec 23, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately. 2 unlinked amendments excluded.

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Company Info

SIC Code: 6282

View on SEC EDGAR

Track this company

Set up alerts to get notified when new Form D filings are submitted.

Track BIOTECHNOLOGY VALUE FUND L P

Want to track companies like BIOTECHNOLOGY VALUE FUND L P?

Set up saved searches and alerts for newly submitted Form D filings.

Offering filing timeline

Dec 23, 2025Form D/A — Amendment

Reported sold: $1,553,132,682 · Target: N/A

No verified predecessor available.

Rule 506(b)·29 investors·Section 3(c), Section 3(c)(1)

Dec 27, 2024Form D/A — Amendment

Reported sold: $1,512,332,682 · Target: Indefinite

Rule 506(b)·27 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Dec 29, 2023Form D/A — Amendment

Reported sold: $1,512,332,682 · Target: Indefinite

Rule 506(b)·27 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Dec 30, 2022Form D/A — Amendment

Reported sold: $1,511,832,682 · Target: Indefinite

Rule 506(b)·27 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jan 4, 2022Form D/A — Amendment

Reported sold: $1,106,082,682 · Target: Indefinite

Rule 506(b)·26 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jan 7, 2021Form D/A — Amendment

Reported sold: $675,082,682 · Target: Indefinite

Rule 506(b)·24 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jan 10, 2020Form D/A — Amendment

Reported sold: $413,832,682 · Target: Indefinite

Rule 506(b)·19 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jan 11, 2019Form D/A — Amendment

Reported sold: $224,032,682 · Target: Indefinite

Rule 506(b)·18 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Dec 8, 2017Form D/A — Amendment

Reported sold: $224,032,682 · Target: Indefinite

Rule 506(b)·18 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Sep 21, 2016Form D/A — Amendment

Reported sold: $212,032,682 · Target: Indefinite

Rule 506(b)·17 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Nov 12, 2014Form D/A — Amendment

Reported sold: $64,755,500 · Target: Indefinite

Rule 506(b)·13 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Nov 8, 2013Form D/A — Amendment

Reported sold: $41,655,500 · Target: Indefinite

Rule 506(b)·14 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors, Exemptions

Nov 8, 2012Form D/A — Amendment

Reported sold: $37,655,500 · Target: Indefinite

Rule 506·12 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold

Nov 8, 2011Form D/A — Amendment

Reported sold: $36,155,500 · Target: Indefinite

Rule 506·12 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Exemptions

Oct 21, 2010Form D — New notice

Reported sold: $34,905,500 · Target: Indefinite

Rule 506·12 investors·Section 3(c), Section 3(c)(7)

Oct 15, 2009Form D/A — Amendment

Reported sold: $29,155,500 · Target: Indefinite

No verified predecessor available.

Rule 506·12 investors·Section 3(c), Section 3(c)(7)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

29

Revenue Range

—

Reported commissions across identified offerings

$0

Amendment Rate

94%

Latest reported sold across 1 identified offering

$1,512,332,682

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

2 unlinked amendments excluded.

Key People

BP

BVF Partners, L.P.

Executive Officer

Appears on 14 filings

BI

Executive Officer

Appears on 14 filings

MD

Matthew D. Perry

Related Person

Appears on 12 filings

MN

Mark N. Lampert

Executive Officer

Appears on 12 filings

JK

Executive Officer

Appears on 9 filings

JM

Executive Officer

Appears on 7 filings

BI

Executive Officer

Appears on 6 filings

BG

BVF GP Holdings LLC

Executive Officer

Appears on 6 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Dec 23, 2025	Amendment	N/A	$1,553,132,682	29
Dec 27, 2024	Amendment	Indefinite	$1,512,332,682	27
Dec 29, 2023	Amendment	Indefinite	$1,512,332,682	27
Dec 30, 2022	Amendment	Indefinite	$1,511,832,682	27
Jan 4, 2022	Amendment	Indefinite	$1,106,082,682	26
Jan 7, 2021	Amendment	Indefinite	$675,082,682	24
Jan 10, 2020	Amendment	Indefinite	$413,832,682	19
Jan 11, 2019	Amendment	Indefinite	$224,032,682	18
Dec 8, 2017	Amendment	Indefinite	$224,032,682	18
Sep 21, 2016	Amendment	Indefinite	$212,032,682	17
Nov 12, 2014	Amendment	Indefinite	$64,755,500	13
Nov 8, 2013	Amendment	Indefinite	$41,655,500	14
Nov 8, 2012	Amendment	Indefinite	$37,655,500	12
Nov 8, 2011	Amendment	Indefinite	$36,155,500	12
Oct 21, 2010	New	Indefinite	$34,905,500	12
Oct 15, 2009	Amendment	Indefinite	$29,155,500	12